Subscribe


Cipla hones in on Melbourne with investment

MUMBAI-based pharmaceutical giant Cipla has opened its Australian headquarters in Melbourne. Cipla is the world's largest manufacturer of antiretroviral drugs for patients with HIV/AIDS and has a turnover of US$1.4 billion per annum and more than 20,000 employees worldwide. One of the first investments by the company in a regional office outside India, the local office was officially opened by Dr Amanda Caples, Executive Director, Science & Technology Programs on behalf of the Victorian Govt. “Through our local staff Cipla will provide superior service to existing customers, build its customer base and provide expert advice to our R&D department on requirements of the Australian medicines market for future product opportunities,” said Oskar Hakansson, Cipla Head - Australia & New Zealand. Hakansson is pictured right with Dr Caples opening the new Melbourne headquarters. MUMBAI-based pharmaceutical giant Cipla has opened its Australian headquarters in Melbourne. Cipla is the world’s largest manufacturer of antiretroviral drugs for patients with HIV/AIDS and has a turnover of US$1.4 billion per annum and more than 20,000 employees worldwide. One of the first investments by the company in a regional office outside India, the local office was officially opened by Dr Amanda Caples, Executive Director, Science & Technology Programs on behalf of the Victorian Govt. “Through our local staff Cipla will provide superior service to existing customers, build its customer base and provide expert advice to our R&D department on requirements of the Australian medicines market for future product opportunities,” said Oskar Hakansson, Cipla Head – Australia & New Zealand. Hakansson is pictured right with Dr Caples opening the new Melbourne headquarters.